eng Science and Education Publishing American Journal of Cardiovascular Disease Research 2024-06-06 9 2 10 16 10.12691/ajcdr-9-2-1 AJCDR2024921 article Desalegn Aychiluhm Abate 1 Senbeta Guteta Abdissa 2 Zekarias Seifu Ayalew 2 Gebeyehu Tessema Azibte gebe10tessema@gmail.com 2 Zelalem Belay Ayele 2 Department of Internal Medicine, Addis Ababa University, College of Medicine and Health Sciences, Addis Ababa, Ethiopia Division of Cardiology, Department of Internal Medicine, Addis Ababa University, College of Medicine and Health Sciences, Addis Ababa, Ethiopia Background: - Globally, cardiovascular diseases (CVD) are the primary cause of death. According to estimates, ischemic heart disease and cerebrovascular illnesses were responsible for 85% of 18 million CVD-related fatalities that occurred globally in 2017. One of the main causative risk factors for atherosclerotic cardiovascular disease is elevated low-density lipoprotein cholesterol (LDL-C). LDL particles can migrate from plasma into the subendothelial region of the artery, where they induce inflammation and lead to the development of atherosclerotic plaques. Thus, LDL-C lowering should be tailored to reach the target objective suggested by guidelines to reduce cardiovascular disease risk. Objective: -Assessment of low-density lipoprotein cholesterol target attainment and associated factors among patients with established coronary heart disease at the cardiology clinic, Tikur Anbessa Specialized Hospital. Methods: - Institutional-based retrospective cross-sectional study design was conducted from August 2023 to October 2023. In this study, among 240 planned participants, 221 participants were extracted, making a chart retrieval rate of 91.7%. Data analysis was done by using SPSS version 26. Multiple regression was applied to identify associated factors. Result: - In this study, about two-thirds of the participants were male, and more than one-third were between the ages of sixty-one and seventy. The level of LDL-C target attainment was 41%. The factors significantly associated with the LDL-C target attainment were male sex (AOR=1.8, 95%CI=1.44, 3.42), hypertension (AOR=0.57, 95%CI=0.31, 0.91), and taking SGLT2 inhibitors (AOR=1.5, 95%CI=1.37, 4.85). Conclusion: The level of LDL-C target attainment was low. Male sex and taking sodium-glucose transporter 2 (SGL2) inhibitors were favorable factors, but hypertension was associated with a low level of LDL target attainment. https://pubs.sciepub.com/ajcdr/9/2/1/ajcdr-9-2-1.pdf low-density lipoprotein cholesterol target coronary heart disease